Caption Management, LLC Inhibrx, Inc. Call Options Transaction History

Caption Management, LLC

  • $6.13 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$14.5 - $38.0 $2.54 Million - $6.67 Million
175,400 New
175,400 $6.67 Million
Q2 2023

Aug 14, 2023
SELL
$16.96 - $27.82 $763,200 - $1.25 Million
-45,000 Reduced 31.03%
100,000 $2.6 Million
Q1 2023

May 15, 2023
BUY
$18.45 - $27.14 $2.68 Million - $3.94 Million
145,000 New
145,000 $2.74 Million

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $617M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email